IT
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni & Conferenze
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni & Conferenze
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
de|fr|it|en
Basilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion ZurigoBasilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion Zurigo
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni & Conferenze
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni & Conferenze
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Dr. Nicolas Mosimann
  • Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.27 agosto 2026
  • Kellerhals Carrard advises on the sale of a majority stake in Hipp Technology GroupKellerhals Carrard advises on the sale of a majority stake in Hipp Technology Group24 marzo 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors11 marzo 2026
  • Deal Ticker: Kellerhals Carrard advised on the sale of LakeraDeal Ticker: Kellerhals Carrard advised on the sale of Lakera6 novembre 2025
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics15 maggio 2025
  • Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.4 aprile 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma3 dicembre 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG27 maggio 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.23 agosto 2023
  • Deal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker CorporationDeal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker Corporation6 gennaio 2023
  • Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.19 dicembre 2022
  • MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.6 aprile 2022